Exploring the Variability in Acute Glycemic Responses to Exercise in Type 2 Diabetes

Table 1

Baseline characteristics.

	MI-CE	HI-IE	Total	𝑃 value
𝑛 (M/F)	4/4	4/3	8/7
T2D duration (yr)	8±4	6±4	7±5	0.41
Body weight (Kg)	93.9±18.3	80.5±9.9	87.7±16.0	0.10
BMI (Kg/m^2)	33.1±4.5	28.4±4.1	30.9±4.8	0.06
Hypoglycemic medication
Metformin alone, 𝑛	4	4	8
Metformin and sitagliptin, 𝑛	1	1	2
Sulfonylurea and metformin, 𝑛	2	0	2
Sulfonylurea and sitagliptin, 𝑛	1	0	1
Fasting blood glucose (mmol/L)	7.3±1.7	6.8±0.8	7.1±1.3	0.48
A1c (%)	6.7±0.9	6.6±0.6	6.7±0.7	0.76
VO2peak  (mL/kg/min)	18.1±2.7	22.8 ± 5.4^a	20.1±4.5	0.10

MI-CE: moderate intensity continuous exercise; HI-IE: high intensity interval exercise; VO_2peak: peak oxygen consumption; A1c: glycated hemoglobin.
𝑃 value refers to comparisons between HI-IE and MI-CE by independent 𝑡-test.
Values are presented as mean ± standard deviation. There was no significant difference between HI-IE and MI-CE.
^a𝑛=6, VO_2peak  was not available for one participant.